| Robert D Taylor, MD | |
|
4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 | |
| (801) 507-5248 | |
| (801) 733-5618 |
| Full Name | Robert D Taylor |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 4401 Harrison Boulevard, Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205842382 | NPI | - | NPPES |
| 820218 | Medicaid | AZ | |
| D0069 | Other | UT | MEDICAL OUTREACH/UMAP |
| 12381 | Other | UT | HEALTHY U |
| 1502954 | Other | UT | UMWA |
| 003068700 | Medicaid | ID | |
| 870545614TA1 | Other | UT | EDUCATORS MUTUAL |
| 107005701101 | Other | UT | IHC |
| 132236 | Other | UT | DMBA |
| 37826 | Other | UT | PEHP |
| 108489500 | Medicaid | WY | |
| 2090168 | Other | UT | UNITED HEALTHCARE |
| QM0000075886 | Other | UT | ALTIUS |
| 100501254 | Medicaid | NV | |
| PRA02807 | Other | UT | MOLINA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 93-261377-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain West Anesthesia Llc | 9032018502 | 248 |
News Archive
A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS.
NIBIB-funded researchers at the Massachusetts General Hospital have developed a smartphone-based device that can reliably carry out molecular diagnoses in under an hour for approximately two dollars per patient. The device could enable point-of-care cancer diagnostics in low- to middle-income or remote areas, which often have high rates of mortality from cancer due to missed opportunities for treatment.
The severity of COVID-19 among the residents of long-term care facilities (LTCFs) has been reported to be disproportionately high. Specifically, individuals residing in skilled nursing facilities (SNFs) are found to be the most severely affected, both in terms of morbidity and mortality, and are, thereby, listed for early COVID-19 vaccination. In comparison to the general population, SNF residents are more vulnerable, with a weak immune system.
The U.S. Food and Drug Administration (FDA) has approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.
New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than those untreated or only treated prior to transplantation.
› Verified 5 days ago
| Entity Name | Mountain West Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558391763 PECOS PAC ID: 9032018502 Enrollment ID: O20040103000057 |
News Archive
A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS.
NIBIB-funded researchers at the Massachusetts General Hospital have developed a smartphone-based device that can reliably carry out molecular diagnoses in under an hour for approximately two dollars per patient. The device could enable point-of-care cancer diagnostics in low- to middle-income or remote areas, which often have high rates of mortality from cancer due to missed opportunities for treatment.
The severity of COVID-19 among the residents of long-term care facilities (LTCFs) has been reported to be disproportionately high. Specifically, individuals residing in skilled nursing facilities (SNFs) are found to be the most severely affected, both in terms of morbidity and mortality, and are, thereby, listed for early COVID-19 vaccination. In comparison to the general population, SNF residents are more vulnerable, with a weak immune system.
The U.S. Food and Drug Administration (FDA) has approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.
New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than those untreated or only treated prior to transplantation.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert D Taylor, MD 3340 North Center St, #800, Lehi, UT 84043-7406 Ph: (801) 990-1911 | Robert D Taylor, MD 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Ph: (801) 507-5248 |
News Archive
A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS.
NIBIB-funded researchers at the Massachusetts General Hospital have developed a smartphone-based device that can reliably carry out molecular diagnoses in under an hour for approximately two dollars per patient. The device could enable point-of-care cancer diagnostics in low- to middle-income or remote areas, which often have high rates of mortality from cancer due to missed opportunities for treatment.
The severity of COVID-19 among the residents of long-term care facilities (LTCFs) has been reported to be disproportionately high. Specifically, individuals residing in skilled nursing facilities (SNFs) are found to be the most severely affected, both in terms of morbidity and mortality, and are, thereby, listed for early COVID-19 vaccination. In comparison to the general population, SNF residents are more vulnerable, with a weak immune system.
The U.S. Food and Drug Administration (FDA) has approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.
New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than those untreated or only treated prior to transplantation.
› Verified 5 days ago
Mark S Naisbitt, M.D., PC Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Phone: 801-507-5248 Fax: 801-733-5618 | |
Dr. John L Haws, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Phone: 801-507-5248 | |
Bryce Larre Egbert, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-2800 Fax: 770-701-6675 | |
Dr. Andrew W. Allen, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-727-2056 Fax: 770-701-6675 | |
Michael Laurence Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Phone: 801-507-5248 | |
Mr. Spencer B Hyde, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Blvd, Ogden, UT 84403 Phone: 801-387-2800 Fax: 770-701-6675 | |
Brian K Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4401 Harrison Boulevard, Mckay Dee Hospital, Ogden, UT 84403 Phone: 801-507-5248 Fax: 801-733-5618 |